The epidermal growth factor receptor (EGFR)/AKT/mechanistic target of rapamycin (mTOR) signaling pathway is one of the most important pathways, which is considered as a master regulator for cancer (Manning & Toker, 2017; Wee & Wang, 2017). This evidence concerns the gene AKT1 and cancer.